Organon & Co | OGN - Trade Debtors


Organon & Co reported $1.48B in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Celltrion KRW 1.51T 128.69B Sep/2025
Cspc Pharmaceutical CNY 8.79B 64.64M Dec/2025
Deva Holding AS TRY 3.03B 343.23M Sep/2023
Dianthus Therapeutics USD 52K 4.95M Dec/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
Gilead Sciences USD 4.91B 182M Dec/2025
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
Kangmei Pharma CNY 3.15B 295.48M Sep/2025
Knight Therapeutics CAD 183M 7.46M Dec/2025
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.48M 174K Dec/2025
Merck USD 12.12B 596M Sep/2025
Neuren Pharmaceuticals AUD 26.54M 5.83M Dec/2025
Novartis USD 12.29B 3.3B Dec/2025
Organigram Holdings CAD 49.94M 14.92M Dec/2025
Organon & Co USD 1.48B 0 Sep/2025
Ovoca Bio EUR 39K 408K Jun/2025
Pharma Mar EUR 60.6M 18.83M Dec/2025
Qiagen NV USD 402.61M 9.05M Dec/2025
Sartorius EUR 366.6M 74.9M Mar/2026
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tilray USD 109.07M 2M Sep/2025
Zealand Pharma A/S 340M 94.1M Dec/2025